Topic List : Cancer

  • Treating rare blood cancers

    Patients with a group of cancers known as advanced systemic mastocytosis have few treatment options. A drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.


  • Creating ‘guided chemotherapy missiles’

    Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.


  • Hope for lymphedema treatment

    Stanford engineers and doctors collaborated with industry to design a possible new treatment for lymphedema, which often affects cancer patients whose lymph nodes become blocked.


  • Owens on colorectal cancer screening

    The health policy expert answered questions about the guidelines he co-authored that strongly recommend adults ages 50 to 75 be screened for colon cancer.


  • Using Mohs surgery for melanoma

    This spring Stanford Health Care began using the Mohs technique for melanoma in situ, which is less expensive than the traditional surgical approach, creates a smaller wound and reduces the cancer’s rate of recurrence.


  • Swetter on choosing sunscreen

    With summer just around the corner, a Stanford dermatologist discusses how to think about SPF labels, how to properly apply sunscreen, the differences between UVA and UVB radiation and more. what to consider when choosing a sunscreen and how to use it properly.


  • Supportive care lacking among dying cancer patients

    All patients with advanced cancer should receive both palliative and hospice care before death, yet a study shows only half of veterans receive palliative care, and the use of hospice depends on the care environment.


  • Immunotherapy offers new hope in treating cancer

    Crystal Mackall will lead a cancer immunotherapy center at Stanford that is being launched with an initial $10 million grant from the Parker Foundation.


  • The way of the nanoparticle

    A growing field called nanotechnology is allowing researchers to manipulate molecules and structures much smaller than a single cell to enhance our ability to see, monitor and destroy cancer cells in the body.


  • IPS cells aid study of chemotherapy side effect

    Doxorubicin is a chemotherapy drug used to treat many cancers, but it causes serious heart damage in some patients. Heart muscle cells made from the skin cells of breast cancer patients can be used to study this phenomenon.